This content is only available to subscribers. Sign up today!

This content is only available to subscribers. Sign up today!
A key gauge of biotechnology stocks is testing major trendline support presently – can it hold yet again? When this market cycle finally comes to…
The bruised and bloodied Biotech sector is testing a trendline that may determine whether it has one more bull bounce – or if its bubble…
A key index of biotechnology stocks may be approaching significant levels of resistance. Throughout the course of the post-February rally, one topic that has been…
If there must be a poster child for the 6-year cyclical bull market, it is likely the biotech sector. At least that is certainly true…
In recent weeks, we have discussed a number of data points indicating elevated levels of hedging in the equity market. This includes examples from the…